Gilead Sciences CDR (GILD.CA) Stock Fundamental Analysis

Canada • Toronto Stock Exchange • TSX:GILD

30.54 CAD
+0.63 (+2.11%)
Last: Feb 5, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

7

GILD gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 24 industry peers in the Biotechnology industry. While GILD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. GILD may be a bit undervalued, certainly considering the very reasonable score on growth These ratings could make GILD a good candidate for value investing.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • In the past year GILD was profitable.
  • In the past year GILD had a positive cash flow from operations.
  • In the past 5 years GILD has always been profitable.
  • GILD had a positive operating cash flow in each of the past 5 years.
GILD.CA Yearly Net Income VS EBIT VS OCF VS FCFGILD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1.2 Ratios

  • With an excellent Return On Assets value of 13.86%, GILD belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • GILD has a Return On Equity of 37.80%. This is amongst the best in the industry. GILD outperforms 100.00% of its industry peers.
  • With an excellent Return On Invested Capital value of 18.54%, GILD belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • GILD had an Average Return On Invested Capital over the past 3 years of 16.22%. This is above the industry average of 11.23%.
  • The 3 year average ROIC (16.22%) for GILD is below the current ROIC(18.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROIC 18.54%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
GILD.CA Yearly ROA, ROE, ROICGILD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

  • GILD's Profit Margin of 27.88% is amongst the best of the industry. GILD outperforms 100.00% of its industry peers.
  • GILD's Profit Margin has declined in the last couple of years.
  • GILD's Operating Margin of 38.96% is amongst the best of the industry. GILD outperforms 100.00% of its industry peers.
  • GILD's Operating Margin has improved in the last couple of years.
  • With an excellent Gross Margin value of 78.72%, GILD belongs to the best of the industry, outperforming 95.83% of the companies in the same industry.
  • In the last couple of years the Gross Margin of GILD has remained more or less at the same level.
Industry RankSector Rank
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
GILD.CA Yearly Profit, Operating, Gross MarginsGILD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so GILD is still creating some value.
  • The number of shares outstanding for GILD remains at a similar level compared to 1 year ago.
  • GILD has less shares outstanding than it did 5 years ago.
  • GILD has a worse debt/assets ratio than last year.
GILD.CA Yearly Shares OutstandingGILD.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
GILD.CA Yearly Total Debt VS Total AssetsGILD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • There is no outstanding debt for GILD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC1.76
WACC10.53%
GILD.CA Yearly LT Debt VS Equity VS FCFGILD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

  • A Current Ratio of 1.53 indicates that GILD should not have too much problems paying its short term obligations.
  • GILD has a Current ratio of 1.53. This is in the better half of the industry: GILD outperforms 62.50% of its industry peers.
  • A Quick Ratio of 1.17 indicates that GILD should not have too much problems paying its short term obligations.
  • GILD has a Quick ratio (1.17) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.17
GILD.CA Yearly Current Assets VS Current LiabilitesGILD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 84.88% over the past year.
  • Measured over the past years, GILD shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.01% on average per year.
  • Looking at the last year, GILD shows a small growth in Revenue. The Revenue has grown by 2.78% in the last year.
  • GILD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.08% yearly.
EPS 1Y (TTM)84.88%
EPS 3Y-14.17%
EPS 5Y-7.01%
EPS Q2Q%22.28%
Revenue 1Y (TTM)2.78%
Revenue growth 3Y1.74%
Revenue growth 5Y5.08%
Sales Q2Q%2.97%

3.2 Future

  • The Earnings Per Share is expected to grow by 19.03% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 3.76% on average over the next years.
EPS Next Y79.63%
EPS Next 2Y39.1%
EPS Next 3Y27.78%
EPS Next 5Y19.03%
Revenue Next Year3.14%
Revenue Next 2Y3.3%
Revenue Next 3Y3.9%
Revenue Next 5Y3.76%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GILD.CA Yearly Revenue VS EstimatesGILD.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
GILD.CA Yearly EPS VS EstimatesGILD.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

10

4. Valuation

4.1 Price/Earnings Ratio

  • GILD is valuated cheaply with a Price/Earnings ratio of 2.73.
  • GILD's Price/Earnings ratio is rather cheap when compared to the industry. GILD is cheaper than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 28.06, GILD is valued rather cheaply.
  • The Price/Forward Earnings ratio is 2.51, which indicates a rather cheap valuation of GILD.
  • Based on the Price/Forward Earnings ratio, GILD is valued cheaper than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.86, GILD is valued rather cheaply.
Industry RankSector Rank
PE 2.73
Fwd PE 2.51
GILD.CA Price Earnings VS Forward Price EarningsGILD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, GILD is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of GILD indicates a rather cheap valuation: GILD is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 2.91
EV/EBITDA 1.3
GILD.CA Per share dataGILD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • GILD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • GILD has an outstanding profitability rating, which may justify a higher PE ratio.
  • GILD's earnings are expected to grow with 27.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y39.1%
EPS Next 3Y27.78%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.12%, GILD has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.48, GILD pays a better dividend. On top of this GILD pays more dividend than 95.83% of the companies listed in the same industry.
  • GILD's Dividend Yield is comparable with the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 2.12%

5.2 History

  • The dividend of GILD has a limited annual growth rate of 4.45%.
  • GILD does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)4.45%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • GILD pays out 12.00% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of GILD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP12%
EPS Next 2Y39.1%
EPS Next 3Y27.78%
GILD.CA Yearly Income VS Free CF VS DividendGILD.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B
GILD.CA Dividend Payout.GILD.CA Dividend Payout, showing the Payout Ratio.GILD.CA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

Gilead Sciences CDR

TSX:GILD (2/5/2026, 7:00:00 PM)

30.54

+0.63 (+2.11%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-30
Earnings (Next)02-10
Inst Owners91.58%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap37.89B
Revenue(TTM)29.09B
Net Income(TTM)8.11B
Analysts81.08
Price Target29.1 (-4.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.12%
Yearly Dividend4.3
Dividend Growth(5Y)4.45%
DP12%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.14%
Min EPS beat(2)0.6%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)5.77%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)6
Avg EPS beat(8)10.36%
EPS beat(12)8
Avg EPS beat(12)8%
EPS beat(16)11
Avg EPS beat(16)5.39%
Revenue beat(2)1
Avg Revenue beat(2)0.99%
Min Revenue beat(2)-0.31%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)8
Avg Revenue beat(12)1.67%
Revenue beat(16)12
Avg Revenue beat(16)2.95%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)-2.7%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.54%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0.51%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 2.73
Fwd PE 2.51
P/S 0.95
P/FCF 2.91
P/OCF 2.87
P/B 1.29
P/tB N/A
EV/EBITDA 1.3
EPS(TTM)11.19
EY36.64%
EPS(NY)12.19
Fwd EY39.91%
FCF(TTM)10.49
FCFY34.34%
OCF(TTM)10.65
OCFY34.87%
SpS32.04
BVpS23.63
TBVpS-5.32
PEG (NY)0.03
PEG (5Y)N/A
Graham Number77.14
Profitability
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROCE 24.51%
ROIC 18.54%
ROICexc 23.24%
ROICexgc 80.87%
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
FCFM 32.73%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
ROICexc(3y)19.38%
ROICexc(5y)17.72%
ROICexgc(3y)93.83%
ROICexgc(5y)93.24%
ROCE(3y)21.45%
ROCE(5y)19.94%
ROICexgc growth 3Y-0.46%
ROICexgc growth 5Y15.06%
ROICexc growth 3Y13.04%
ROICexc growth 5Y6.39%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 68.56%
Profit Quality 117.39%
Current Ratio 1.53
Quick Ratio 1.17
Altman-Z N/A
F-Score7
WACC10.53%
ROIC/WACC1.76
Cap/Depr(3y)25.08%
Cap/Depr(5y)29.48%
Cap/Sales(3y)2.21%
Cap/Sales(5y)2.28%
Profit Quality(3y)819.86%
Profit Quality(5y)1749.07%
High Growth Momentum
Growth
EPS 1Y (TTM)84.88%
EPS 3Y-14.17%
EPS 5Y-7.01%
EPS Q2Q%22.28%
EPS Next Y79.63%
EPS Next 2Y39.1%
EPS Next 3Y27.78%
EPS Next 5Y19.03%
Revenue 1Y (TTM)2.78%
Revenue growth 3Y1.74%
Revenue growth 5Y5.08%
Sales Q2Q%2.97%
Revenue Next Year3.14%
Revenue Next 2Y3.3%
Revenue Next 3Y3.9%
Revenue Next 5Y3.76%
EBIT growth 1Y4.49%
EBIT growth 3Y2.36%
EBIT growth 5Y12.88%
EBIT Next Year76.07%
EBIT Next 3Y25.58%
EBIT Next 5Y19.27%
FCF growth 1Y21.23%
FCF growth 3Y-1.57%
FCF growth 5Y4.37%
OCF growth 1Y15.03%
OCF growth 3Y-1.66%
OCF growth 5Y3.44%

Gilead Sciences CDR / GILD.CA FAQ

What is the ChartMill fundamental rating of Gilead Sciences CDR (GILD.CA) stock?

ChartMill assigns a fundamental rating of 7 / 10 to GILD.CA.


What is the valuation status for GILD stock?

ChartMill assigns a valuation rating of 10 / 10 to Gilead Sciences CDR (GILD.CA). This can be considered as Undervalued.


How profitable is Gilead Sciences CDR (GILD.CA) stock?

Gilead Sciences CDR (GILD.CA) has a profitability rating of 9 / 10.


What is the valuation of Gilead Sciences CDR based on its PE and PB ratios?

The Price/Earnings (PE) ratio for Gilead Sciences CDR (GILD.CA) is 2.73 and the Price/Book (PB) ratio is 1.29.


How sustainable is the dividend of Gilead Sciences CDR (GILD.CA) stock?

The dividend rating of Gilead Sciences CDR (GILD.CA) is 5 / 10 and the dividend payout ratio is 12%.